Helveteq is an issuer and product manufacturer specialising in exchange traded and non-listed investment products. We structure and issue ETPs, nETPs and AMCs for financial intermediaries and coordinate the full product lifecycle.
No. Helveteq does not provide investment advice, portfolio management or distribution services. All information on this website is provided for informational purposes only.
No. Helveteq does not accept subscriptions or execute transactions. Investments can only be made via a bank or broker.
Helveteq issues:
- Exchange Traded Products (ETPs)
- Non-listed Exchange Traded Products (nETPs)
- Actively Managed Certificates (AMCs)
These products can be structured across traditional and digital assets, private debt and real estate-related exposures
Listed ETPs are issued under a SIX-approved base prospectus and admitted to trading on the SIX Swiss Exchange. Non-listed products are structured in accordance with the applicable legal and regulatory framework.
Helveteq products can be bought and sold via banks or brokers using standard securities identifiers. All execution and suitability processes are handled by the respective institution.
Helveteq products are structured within a fully collateralised framework, with independent custodians and security agents appointed as described in the product documentation.
Sustainability-related aspects may be integrated through transparent disclosures where applicable. Relevant information is available in the product documentation, including SFDR-related disclosures where required.
All legally binding documents, including the Base Prospectus, Final Terms and Key Information Documents (KID), are available on this website.
Helveteq AG acts as issuer and product manufacturer. Banks and brokers act as distributors and execution venues unless explicitly stated otherwise.
An Exchange Traded Product (ETP) is a fully collateralised bearer debt security listed on a regulated exchange and designed to replicate the performance of an underlying asset or strategy, subject to the product terms.
ETPs are listed products issued under a SIX-approved base prospectus.
nETPs follow similar structuring principles but are not listed on an exchange.
AMCs are actively managed certificates that may, depending on the regulatory regime and target market, be issued without a prospectus.
Yes. Helveteq products are bearer debt securities and therefore subject to issuer risk. This risk is mitigated through a fully collateralised structure, but it cannot be eliminated entirely.
In the event of an issuer default, the pledged collateral is enforced for the benefit of investors in accordance with the security structure described in the Base Prospectus and Final Terms.
No. Helveteq products are not guaranteed and do not provide capital protection unless explicitly stated in the Final Terms of a specific product.
The net asset value (NAV) is calculated in accordance with the methodology described in the product documentation and is typically verified by an independent administrator. Market prices may differ from NAV due to supply and demand.
Liquidity depends on market conditions and the involvement of market makers or authorised participants. Trading prices may differ from NAV.
Redemption features depend on the specific product structure and are described in the applicable Final Terms. Early redemption is not guaranteed.
Banks, brokers, market makers, custodians, security agents, paying agents and calculation agents support issuance, trading, settlement and lifecycle management, each acting within their respective regulatory frameworks.
Depending on the structure and applicable regulatory treatment, Helveteq products may be used by regulated financial institutions to transfer asset exposures and associated risks to investors. Any balance sheet or capital impact depends on the institution’s internal policies and applicable regulations.
No. Helveteq does not provide regulatory, capital, tax or accounting advice. Institutions and investors must rely on their own advisers.
Helveteq does not assess investor suitability. Any suitability or appropriateness assessment is performed exclusively by the investor’s bank or broker.
Product-related fees are disclosed in the Final Terms and product documentation. Additional fees may apply at the level of the investor’s bank or broker.
Where applicable, sustainability-related information is disclosed in accordance with SFDR requirements. Disclosures are based on available data and methodologies described in the product documentation.